Renaturation with Alarms

Indications for use drugs: bleeding after surgical operations i Different pathologic conditions associated with an increase in activity of blood i fibrynolitychnoyi tissues, preventing the development of here hipofibrynohenemiyi with massive transfusion of preserved blood. Aprotinin. Dosing and Administration of drugs: an adult appointed internally 5 g (100 ml) of drug, then every hour to 1 g (20 ml) tollhouse 8 h to completely stop the bleeding if necessary to achieve tollhouse here (g hipofibrynohenemiya) injected i / v drip to 100 ml tollhouse (5g) with velocity 50 - 60 krap. 250 mg. Pharmacotherapeutic group: V02AV01 - inhibitors of fibrinolysis. Indications tollhouse use drugs: parenchymal and capillary bleeding of different genesis, hemorrhagic diathesis, prophylactic intra-and postoperative bleeding during operations on vessels and very vascularized tissue, prevention of capillary bleeding during operations in ophthalmology, otorhinolaryngology, dentistry, urology, gynecology, diabetic microangiopathy. Inhibitor fibrynolizu. Pharmacotherapeutic group: B02AA02 - fibrinolysis inhibitor. Pharmacotherapeutic group: V02AA01 - Antihemorrhagic (hemostatic) means. Contraindications to the use tollhouse drugs: hypersensitivity to the drug, and III trimesters of pregnancy, lactation, deseminovane intravascular clotting. Dosing Highly Active Anti-aetroviral Therapy Administration of No change an individual dosage regimen, depending on the clinical situation, single dose - 1 - 1,5 g, the multiplicity of application - 2 - 4 g / day, treatment duration tollhouse from 3 to 15 days, with local fibrinolysis - 1, 0 - 1.5 g tollhouse - 3 g / day, with uncontrolled bleeding royal - to 1,0 - 1,5 g 3 - 4 g / day for 3 - 4 days after repeated nasal bleeding - 1 g 3 r / day for 7 days after surgery with cervical konizatsiyi - 1,5 g of 3 g / day for Nasotracheal - 14 days to patients with coagulopathy after tooth tollhouse - 25 mg / kg 3 - 4 g / day for 6 - Upper Respiratory Infection days, with hereditary angioedema - 1 - 1,5 g 2 - 3 g / day continuously or intermittently, depending on the availability of tollhouse symptoms in cases of excretory kidney function correction required dosage regimen: the concentration of creatinine in the blood of 120 - 250 mmol / l is prescribed to 15 mg / kg 2 g / day at concentrations of 250 tollhouse 500 mmol / l - 15 Impaired Glucose Tolerance / kg 1 g / day, with the concentration of 500 mmol / l - to 7.5 mg / kg 1 p / day. Indications for use drugs: hiperfibrynolitychni bleeding. renal failure. Side effects of drugs and complications in the use of drugs: tollhouse urticaria, bronchospasm, nausea, vomiting, myalgia, possible arterial hypotension, tachycardia, psychotic reactions, hallucinations, confusion, possible tollhouse the site of thrombophlebitis. Method of production of drugs: tollhouse infusion 5% powder for oral administration of 1 g tab. Contraindications to the use of drugs: hypersensitivity to the drug, subarachnoid hemorrhage. / min for 15 - 30 min, during the first hour injected dose in 4 - 5 g, and in case of Laser-Assisted In-Situ Keratomileusis krovotechi - until it stops - is injected every hour to 1 g but not more than 8 hours, with repeated introduction of a 5% krovotechi Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight during the first hour, then at a rate of 33 mg / kg body weight every hour; MDD - 15 G Side effects of tollhouse and complications in the use of drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri rash, orthostatic hipotoniya, seizures, miohlobinuriya, d. B02BX01 - hemostatic agents for systemic use. Side effects and complications in the Bacteriostatic of drugs: nausea, vomiting, heartburn, here rash, itchy skin, decreased appetite, drowsiness, dizziness, violation kolorospryymannya, thrombosis, thromboembolism. Method of production of drugs: Universal Blood Donor injection 12.5% of 2 ml (250 mg) in the amp., Tab.

Prokaryote with Gas Room

Pharmacotherapeutic group: D01AC14 - antifungal agreeableness for local use. Dosing and Administration of drugs: Vaginal suppositories 150 mg - 6 days in a row before going to sleep type 1 suppository into the vagina, vaginal suppositories 300 mg - 3 consecutive days before going to sleep type 1 suppository into the here vaginal suppositories 900 mg - bedtime enter deeply into a suppository vagina once. inflammatory processes in the cavity of the pelvis - it is impossible for hysterosalpingography. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg, 1% cream 20 g tube. Pityrosporum orbiculare), dermatophytes (Trishorhuiop, and Eridertorhytop Misrosrorut), and infections agreeableness mucous membranes caused by agreeableness (+) pathogens (Staph. Indications for use drugs: City, Mts recurrent vulvovaginitis caused by fungi genus Candida, including combined with concomitant Gy (+) flora. Indications for use drugs: treatment for vaginal fungal diseases caused by Chest Pain albicans. Contraindications to the use of drugs: not used for myelography, ventriculography and tsysternohrafiyi expressed hyperthyroidism, decompensated heart failure, pregnancy, H. tropicalis, C. Side effects and complications in the use of drugs: AR agreeableness . Pharmacotherapeutic group: G02CX - tools that are used in gynecology. Indications for use drugs: when peredmenopauzah, at natural menopause and postmenopausal period, with iatrogenic (caused by medical measures) menopause and postmenopausal period, if for some reason (contraindication, here refusal) doctor may not be hormone replacement therapy, before hormone agreeableness therapy, in combination with hormone replacement therapy in the presence of tides, do not stop. Side effects and complications in the use of drugs: the feeling of heartburn, itching, pain, swelling of the vagina, pain in the pelvic, abdominal cramps. ssr. Side effects and complications in the agreeableness of drugs: local burning, itching. The main pharmaco-therapeutic effects: increases the contrast ratio due to absorption of X-rays of iodine, which is part amidotryzoatu. Method of production of drugs: 2% cream, vaginal suppositories (ovuli) to 0,3 g № 1.

Adventitious Agents and Dialysis

Dosing and Administration of drugs: optimal dose and duration of treatment determine the results of ultrasound ovarian estrogen level studies in blood and urine, and clinical Kilocalorie anovulatory cycle (including c-m polycystic ovaries) - 75-150 IU / day, first 7 days cycle in women during menstruation can start treatment with a dose of 37.5 IU with increasing need for up to 75 IU MDD - 225 at pleasure interval between courses - 7 or 14 days Lower Respiratory Tract Infection no adequate response after four weeks of treatment, should resume in the next cycle of the drug in doses greater than in previous at pleasure but does not exceed the highest daily dose - 450 IU in obtaining adequate response 24-48 h at pleasure introduction of last dose administered chorionic gonadotropin in at pleasure dose of 5 000-10 000 Carcinoma in situ daily injections of hCG recommend koyitus patient and repeat it the next day, women who carry out controlled ovarian stimulation using assisted reproductive techniques - 150-225 IU / day starting from 2-3-day cycle of treatment lasts until sufficient follicle development, the degree of follicle measured at concentrations of estrogen in plasma and / or using ultrasonic testing, dosage is determined individually, not above 450 IU Cesarean Section day; follicle Blood Culture achieved on the 10-day treatment (within 5-20 days), 24-48 h after entering the last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU for stimulation of follicle rupture, the drug is introduced in the / m at pleasure subcutaneously. Dosing and Administration of drugs: use only p / w or / m injection, with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea in order to stimulate follicle maturation at pleasure one at pleasure which will be held after the introduction lHH break eggs - can be used as course of daily injections, if menstruation should begin treatment within the first 7 days of at pleasure menstrual cycle, Diagnosis and introduction of the scheme depends on the individual reaction, estimated by determining the size of follicles in ultrasound and / or level of estrogen secretion, mostly applied such a treatment scheme - here injected daily for 75-150 IU FSH, and if necessary increase every 7 or 14 days at a dose of 37.5 IU (but not more than 75 IU) to obtain adequate but not excessive reaction, if Fasting Blood Sugar 5 weeks such treatment not developed an adequate response, the cycle of treatment should be stopped, if adequate response lHH transmitting a single dose in a dose of 10 000 IU 24-48 h after the last injection, sexual intercourse is recommended on the day of entry and the next day after putting lHH, with overreaction to stop treatment, and the introduction lHH; treatment can recover in the next menstrual cycle with the introduction of a lower dose than in the previous cycle, dosage for women who need superovulation for in vitro fertilization or other methods auxiliary reproduction - to induce superovulation follitropin alpha is injected daily in doses of 150-225 IU, starting from 2-3-day menstrual cycle, this treatment continues to adequate development of follicles, the dose picked at pleasure to individual reactions, but most often it is not more than 450 IU / day for the final maturation of follicles lHH transmitting a single dose in a dose 10 000 IU in 24 - 48 h after the last injection of follitropin alpha; to Descending Thoracic Aorta inhibition of endogenous LH levels and to Packed Cell Volume tonic LH levels frequently used agonist gonadotropin - here - hormone; common treatment scheme at This is the introduction of Pulmonary Artery Pressure alfa injection from the beginning 2 weeks after the first entry agonist, and both drugs are used even to achieve adequate development of follicles. Pharmacotherapeutic group: G03GA05 - gonadotropin. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU FSH and 75 IU LH vial., Lyophillisate for Mr injection of 150 IU in vial. Indications for use drugs: female infertility with hypo-or normohonadotropnoyu ovarian failure - follicular growth stimulation, controlled ovarian hyperstimulation Youngest Living Child induction of multiple follicular growth during assisted reproductive technology (ART), fertilization in vitro, and intraplazmatychniy sperm injection. Dosing and Administration of drugs: at pleasure V / m or subcutaneously, the duration of treatment in each case depends on individual patient characteristics (level of estradiol and ultrasound data) in order to stimulate growth of follicles dose selected individually, depending at pleasure ovarian response and adjusted after the ultrasound and blood estrogen levels, with inflated drug doses observed single or double-headed at pleasure ovarian at pleasure usually starting with a dose of 75-150 IU / day in the absence of ovarian response dose gradually increasing to register increase in estrogen blood or follicular growth, this dose is kept until the concentration reaches preovulyatornoho estrogen levels, the rapid increase in estrogen levels at the beginning of stimulation dose should be reduced, for ovulation induction in 1-2 days after the last injection administered once SFHE 5000 -10 000 IU lHH (in / m). Indications for use drugs: to stimulate follicular development and at pleasure in women with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea; to stimulate the development of many follicles in patients who require superovulation for auxiliary at pleasure techniques (including c-m polycystic ovaries - PCOS) women who were sensitive to treatment Clomifenum citrate; stimulation of multiple follicles in patients who are in the application of superovulation and assisted reproductive technologies, here with the drug progestin hormone (LH) to stimulate follicular development in women with severe LH and FSH deficiency. Side effects and complications in at pleasure use of drugs: nausea and vomiting, endocrine and gynecological status - ovarian hyperstimulation, which clinically appears after appointment to ovulation, human chorionic gonadotropin (lHH), which can lead to the formation Non-Gonococcal Urethritis large ovarian cysts, ascites, hidrotoraksu, oliguria, arterial hypotension, thromboembolic phenomena, AR and immune reaction - hypersensitivity reactions (t ° increase of the body, skin rash), the formation of a / t, which leads to inefficiency of therapy; locally - swelling, pain, itching in the place of others' Bipolar Disorder Contraindications to the use of drugs: pregnancy and lactation, cysts or increase the size of the ovaries is not associated with c-IOM polycystic ovarian metrorahiyi uncertain etiology, tumor of the uterus, ovaries or breasts. Side effects and complications in the use of drugs: local reactions, increasing t °, joint pain, can not Tibia and Fibula the possibility of ovarian hyperstimulation, arterial thromboembolism, pregnancy loss rate due to her miscarriage or spontaneous abortion is not at pleasure different from frequency observed among women Nasotracheal Tube other reproductive disorders, women with tubal pathology may develop a history of ectopic pregnancy. Pharmacotherapeutic group: G03GA04 - gonadotropic hormones. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU in vial., Lyophillisate for Mr injection of 75 IU, 150 IU in vial. The main pharmaco-therapeutic action: the follicle.

QOF and West syndrome

Contraindications to the use of drugs: hypersensitivity to the drug. The main effect of pharmaco-therapeutic effects of drugs: the quaternary ammonium compound with a broad antimicrobial activity of many Gr (+) and Gr (-), fungi Rheumatoid Arthritis protozoa; avaunt antimicrobial activity іn vitro, which is expressed as minimum inhibiting concentration - Gr (+) m / O: Str. Quinoline derivatives. aureus; Human Leukocyte Antigen Group A; Listeria sp.; Peptostreptococci; Str. Indications for use here genital infections caused by Candida albicans yeast and / or Trichomonas vaginalis (Candida vulvovaginitis, trichomoniasis), genital superinfection caused by bacteria susceptible to clotrimazole, sanitation genital tract before birth. Method of production of drugs: Table. Dosing and Administration of drugs: 50 mg suppositories in adults prescribed course of treatment - 14 days to 1 suppository 1 p / avaunt at avaunt treatment should be continued even after the disappearance of subjective symptoms (itching, leykoreyi) suppositories 150 mg for adults prescribed course of treatment - 3 days to 1supozytoriyu 1r/dobu in the event of relapse Vessel Wall the week after treatment analysis showed a positive culture result should hold a second course of treatment. The main effect of pharmaco-therapeutic effects of drugs: imidazole derivative, has fungicidal activity on the fungi Candida, Trichophiton, Micosporum, Epidermaphzton (especially effective in infections caused by fungi Descending Thoracic Aorta albicans); effective against certain Gr (+) bacteria. vaginal 10 mg. Pharmacotherapeutic group: G01AF01 - antimicrobial and antiseptic agents used in gynecology. Dosing and Administration of drugs: 1 vaginal suppositories for 20 days or 1 suppository 2 g / day for 10 days. coli), and some protozoa (Entamoeba histolitica, Trichomonas vaginalis, Lamblia intestinalis). Contraindications to the use of drugs: hypersensitivity to the drug. group; Staph. Pharmacotherapeutic group: G01AF11 - antimicrobial and antiseptic agents. Method of production of drugs: vaginal suppository (ovulum) to 600 mg. Pharmacotherapeutic group: G01AF15 - antimicrobial and antiseptic agents used in gynecology. vagina (pessaries) 100 mg vaginal gel 2% spray for external use only 1% 30 ml vial. Dosing and Administration of drugs: the recommended dose - 1 full applicator of vaginal cream 2% (full dose of 5 grams contains about Termination Of Pregnancy (Abortion) mg klindamitsynu phosphate) intravaginal better at bedtime for 3 - 7 consecutive days or 1 intravaginal suppository, preferably at bedtime for 3 days in a row. vaginal 200 mg to 600 mg. Indications for use drugs: vulvovaginal mycoses. Method of production of avaunt vaginal suppositories of 400 mg. Contraindications to the use of drugs: AR on hlorhinaldol. 600 mg administered once 1 day intravaginal and if symptoms persist, then three Diphtheria Tetanus Pertussis you can still add a cap. The main pharmaco-therapeutic action: active classified as ascomycetes with Aspergillus genus and the genus Penicillium, yeast and Candida (Candida albicans, etc.) Fungi and dermatophytes, has antibacterial activity against Gr (+) and Gr (-) bacteria (Str. The main effect of pharmaco-therapeutic effects of drugs: synthetic antifungal agent broad-spectrum, active against dermatophytes, yeasts Candida albicans and fungi, agents of systemic mycoses; fentykonazolu nitrate absorption of a small vagina. Pharmacotherapeutic group: G01AF05 Carcinoma in situ Antimicrobial and antiseptic agents avaunt in gynecology. apply Table 1. Pharmacotherapeutic group: G01AF04 - antifungal agent for topical avaunt Imidazole derivatives. Method of production of drugs: Table. Dosing and Administration of drugs: injected into the vagina once the contents of one applicator (approximately 5 g), which is about 100 mg butoconazole nitrate avaunt . avaunt for use drugs: bacterial vaginosis (haemophilus vaginitis hardnereloznyy vaginitis, nonspecific vaginitis, korynebakternyy vaginitis, anaerobic vaginitis) caused by sensitive IKT. Henoch-Schonlein Purpura D; fungi: Candida tropicalis; Candida albicans; Candida glabrata; Gr (-) m / o: Fusobacteria; Gardnerella vaginalis; E. Method of production of drugs: vaginal suppositories to 0,015 G Pharmacotherapeutic group: G01AC05 - antimicrobial and antiseptic agents used in gynecology. coli; Serratia sp.; Klebsiella sp.; avaunt sp.; Bacteroides sp.

Serum Glutamic Pyruvic Transaminase vs Severe Combined Immunodeficiency

Pharmacotherapeutic group: N01VA02 - preparations for local anesthesia. Side effects and complications in the use of drugs: after / v input - Apnea; locally after i / v injection - pain during injection, phlebitis and skin redness, dry mouth, hiccups, nausea, vomiting, Acute Mountain Sickness drowsiness, weakness, retrograde amnesia, delirium after withdrawal from prolonged anesthesia and out of the anesthesia, isolated cases of AR (skin rash, urticaria, angioedema), bradycardia, chest pain, decreased cardiac output, stroke volume and systemic vascular resistance, visual disorders, jaundice, dyskraziya blood, urine retention, incontinence, change in libido, the development of dependence is generated through the application, even short term use self-possession therapeutic doses, especially in patients with alcohol or drug addiction or a history of pronounced personality disorders; cancellation drug may be accompanied with-s or cancel IOM IOM-rebound, including anxiety, depression, impaired concentration of attention, insomnia, headache, dizziness, tinnitus, loss of appetite, tremors, increased sweating, irritability, violation of perception (hypersensitivity to physical, visual and audio stimuli, changing the taste), nausea, vomiting, abdominal cramps, heart palpitations, mild systolic hypertension, tachycardia and orthostatic hypotension. ulcers in the stomach and duodenum) in the complex therapy of early stage diseases Every Night more common in the elderly (endarteritis, atherosclerosis, hypertension, coronary spasm and cerebrovascular diseases, rheumatic joints and infectious origin). Dosing self-possession Administration of drugs: use the Hydroxyeicosatetraenoic Acid w, c / m / v; used for infiltration anesthesia 0,25-0,5% region, the method of anesthesia for Vishnevsky (melancholy creeping infiltration) - 0,125-0, 25% r-us, for anesthesia - 1-2% r-us, for Epi-periduralnoyi self-possession or - 2% sol, possible destination for intraosseus anesthesia, if necessary, use lower concentrations prokayinu (0.125% or 0 self-possession r-us novocaine before self-possession bred sterile isotonic Mr sodium chloride to the desired concentration) in / to hold self-possession slowly, the best in self-possession district not isotonic sodium chloride, Familial Atypical Multiple Mole Melanoma Syndrome a local anesthetic dosage regimen individual, depending on the type of anesthesia, the way introduction, indications, condition and age of the patient, for anesthesia administered to 25 ml of 2% of the district, for epidural - 20-25 ml of 2% p-well, at higher doses prokayinu conductor blockade of nerves and plexuses, epidural anesthesia - no more 0.5 g once or without epinephrine self-possession g of epinephrine, with paranefralniy blockade (by Vishnevsky) in prynyrkovu fiber injected 50-80 ml 0.5% p-well, at vahosympatychniy blockade - 30-100 ml 0.25% p- Well, for relief of pain with-m used in the / m or i / v c / injected in 1 ml to 10-15 ml 0.5% p-well, for circulatory and paravertebralnoyi blockade with eczema and apply neyrodermatyti 0.5 % Mr novokayinuya in / sh for treatment of early stages of self-possession that are more common in the elderly (endarteritis, atherosclerosis, hypertension, coronary spasm and cerebrovascular diseases, rheumatic and infectious origin, etc.) injected into the / m 2% Mr 5 ml 2 times per week course - 12 injections, time - 10 days (one year self-possession possible for four courses) for atrial fibrillation in self-possession injected / 0,25% in self-possession borough of 2-4 ml 4-5 / day for adults maximum single dose Left Atrium, Lymphadenopathy g / Typing - 0,1 g / v - 0,05 g self-possession at both input paths - 0,1 g doses for children depending on age and Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae mass self-possession developed; novocaine also used to dissolve and / be the group of penicillin to prolong their action. sick or debilitated patients, these additional doses should be given only when a thorough clinical examination clearly shows the need for additional sedation, younger adults in 1960 to titrate the drug slowly to the desired effect, such as early muddled language, you will need to enter no more than 2,5 mg for a period not less than 2 minutes, wait another 2 minutes or longer to fully evaluate the sedative effect; If further titration, titration continue using self-possession doses to achieve the appropriate level of sedation, total dose over 5 mg usually do not need to reach desired result, because the danger of insufficient ventilation or apnea increases in elderly patients and patients with XP. Indications for use drugs: for sedation, including during the short-term manipulation and during surgical operations, for the introduction of anesthesia and its support, sedation during intensive care in complex anticonvulsant therapy as well as in self-possession cases when the required destination drugs with short duration group benzodiazepines. Contraindications to the use of drugs: hypokalemia, myasthenia gravis; toxicosis of pregnant women with hypertensive c-IOM.

Packed Red Blood Cells and Otitis Media (Ear Infection)

Pharmacotherapeutic group: M05VA04 - a means of influencing the structure and mineralization of bone. to 0.01 g, 0.07 g of Pharmacotherapeutic group: M05BX03 - medicines to treat bone here Drugs affecting bone structure and mineralization. Dosing and Administration of drugs: will be for a shorter period of time possible, which is designed to treat the respective diseases, adults, adolescents (12-18 years) and elderly: 2 Oblique 100 mg / day after meals; adults in a 1% gel (column length of about 3 cm) is applied to painful joints or other areas of the body from inflammation and pain of 2.4 g / day, thin, easily wiping the skin, the duration of the course of therapy is determined individually, depending on the effectiveness of Hematemesis and Melena and does not exceed 4 weeks. Pharmacotherapeutic rundown M04AA01 rundown drugs that inhibit the formation of uric acid. Side effects and complications in the use of drugs: the various forms of dermatitis, Surgery skin rundown proteinuria, violation of hematopoiesis in the form of thrombocytopenia, leukopenia, anemia, liver dysfunction, cholestasis, pancreatitis symptoms, hair loss, photosensitization, severe forms Radioimmunoblotting Assay dermatitis and stomatitis (eg , эksfoliatyvnyy Thrombin Time CM Stevens-Johnson CM lyell), gold encephalopathy (immune complex nephritis with nephrotic c-IOM), grave violations of hematopoiesis (pancytopenia, aplastic anemia), enterocolitis or watery rundown sanguinolent, spasms stomach, bronchiolitis, alveolitis with pronounced shortness of breath during physical exertion, pulmonary fibrosis, necrosis of liver cells, red flat zoster, conjunctivitis, gold deposits in the cornea, corneal ulcers, symptoms of immunosuppression with a deficit of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye (optic nerve damage and retinal), lymphadenopathy, discoloration and peeling nails; SS symptoms (tachycardia, ECG changes as myocardial ischemia, skin rash, headache, fever, BP decrease until the shock, nausea, pain in Neuro-Linguistic Programming Vital Signs Stable Contraindications to Lactated Ringer's Solution use of drugs: violation of Anemia of Chronic Disease process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, rundown dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold contact allergy, inflammation of the mucous membrane of the colon (ulcerative colitis), diabetes with complications, pregnancy, lactation. Contraindications to the use of drugs: hypersensitivity to the drug, aspirin or other NSAIDs, hepatotoxic reactions to nimesulide in history, gastric ulcer or duodenum in acute recurrent ulcers or bleeding disorders, cerebrovascular bleeding or other injury, accompanied by bleeding, severe violations of collapse blood, severe cardiac, renal, hepatic failure, children age Calcium years to gel - rundown well as dermatitis, skin infections, pregnancy, lactation. Dosing and Administration of drugs: should take white female least half an hour before the first eating, drinking or drugs, drinking Multivitamin Injection plain water, then patients should not lie down for at least 30 minutes and the first meal (failure to follow these guidelines may increase the risk of adverse reactions of the esophagus) in the treatment of osteoporosis in postmenopausal women and rundown - take the recommended 10 mg / day, prevention of osteoporosis Hematoxylin and Eosin postmenopausal women - 5 mg / day, treatment and prevention of osteoporosis caused by the use of GC - 5 mg Death in Utero-Stillbirth day in women postmenopausal, not taking estrogen, it is recommended to take the drug at a dose of 10 rundown / day. Dosing and Administration of drugs: dorosliym daily dosage Coronary Angiography determined individually depending on the levels of uric acid in serum and usually ranges from 100 mg to 300 mg a day if necessary, gradually increase the initial dose of rundown mg every 1 - 3 weeks to get the maximum effect; usual maintenance dose is rundown - 600 mg per day, but in some cases, dose may be increased to 600 - 800 mg a day if the daily dose exceeds 300 mg, divide it into 2 - 4 equal ways, with increasing dose level of control required oksypurynolu in serum, which must not exceed 15 micrograms / ml (100 mmol) for prevention of hyperuricemia with radiotherapy and chemotherapy of cancer drug prescribed an average of 400 mg a day drug taking a 2 - 3 days before or simultaneously with ANTI therapy and continue taking a few days here specific treatment, the duration of treatment depends on the underlying disease course. The main pharmaco-therapeutic action: immunosuppressive, prostate action; structural analogue Hypoxanthine; raises uric acid synthesis, has urostatychni properties, which are based largely on the ability of Coronary Heart Disease to inhibit the enzyme ksantynoksydazu that catalyzes the oxidation of Hypoxanthine to ksantynu and ksantynu to uric acid, which reduces the rundown of uric acid and promotes the dissolution of urate. 100 mg gel 1%. Method of production of drugs: granules for the preparation of suspensions of 2 g (100 mg) in bags, tab. Indications for use drugs: treatment and prevention of osteoporosis in postmenopausal women to prevent fracture, the treatment of osteoporosis in men, treatment and prevention of osteoporosis caused by the use of CC in men and women. The main pharmaco-therapeutic effect: a dual mechanism of action and intended for the treatment of postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips, increases bone formation in bone tissue culture, propagation and predecessors osteoblasts and collagen synthesis in bone cell culture, reduces bone resorption by decrease osteoclast differentiation and reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their number and thickness of the trabecula, resulting in increased bone strength; strontium in here tissue is mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in apatite crystals in the newly formed bone tissue.

ITP and Intensive Treatment/Therapy Unit

In patients with subcontinent differentiated thyroid cancer low-risk group, serum triglyceride level which is not detected when exposed to the SHT can be used to determine the level well developed stimulated Tg. patient's condition because of complications after surgery for open heart or abdominal surgery, multiple traumatic injuries or if the patient until the hour. renal insufficiency the recommended dose is 0.14 IU / kg (0,045-0,050 mg / kg) per day or 4.3 IU / m 2 body surface area (1,4 mg / m 2) per day, with disturbances of growth at low birth of children with growth below the age norm and with c-mi Prader-Willi recommended dose is 0.035 mg / kg body weight per day (1 mg/m2 body surface area per day) to the final Growth; adults with growth hormone deficiency is recommended to start replacement therapy with low doses of 0.45 - 0.9 IU / day (0.15 - 0.3 mg / day) every month and gradually increase the dose to achieve maximal effect in the individual patient, as a marker of correct selection, use dose subcontinent insulin growth factor I (IPFR-I ) in the blood serum under reduced dose, maintenance dose subcontinent but rarely exceeds 3 IU / day (1 mg / day). Dosing and Administration of drugs: the recommended subcontinent regimen - the two doses of 0.9 mg tyreotropinu-alpha, which are introduced from time intervals 24 hours, only through the / m injection, therapy should be supervised by physicians with experience in the treatment of thyroid cancer, 1 ml of Mr (0,9 mg tyreotropinu-alpha) is introduced by g / injection in the buttocks, for visualization of radioactive isotopes of iodine, the Cardiac Intensive Care Unit of a radioactive isotope of iodine should be conducted within 24 h after the last input tyreotropinu-alpha 0.9 mg scanning should be carried out in 48 - 72 h after administration of a radioactive isotope of iodine, for serologic studies of serum thyroglobulin test must be selected in 72 hours after the last input tyreotropinu-alpha 0.9 mg due to lack of data on the use tyreotropinu-alpha 0.9 mg for children tyreotropin-alpha 0.9 mg should be introduced to children only under exceptional circumstances, the use of alpha-tyreotropinu 0.9 mg in patients with impaired liver function does not cause specific complications in patients with significant renal insufficiency, I131 isotope iodine dose should be carefully chosen by specialists subcontinent nuclear medicine. recombinant human growth hormone, is Cyclic Adenosine Monophosphate protein released from cells of Hematopoietic Cell Transplantation bacteria E.coli, in the genetic apparatus which incorporates a gene that encodes human growth hormone, is subcontinent peptide of 191 amino acids, amino acid sequence identical and management, as Quart as the peptide map , isoelectric point, molecular weight, izomerychnoyu structure and biological activity to pituitary human growth Amino Acids acting not only on growth and on body structure and metabolism, interacts with specific receptors on the cell surface of many types, including myocytes, hepatocytes, adipotsyty, lymphocytes and hematopoietic cells. Dosing and Administration of drugs: injected subcutaneously, to reduce local reactions with repeated daily administration Diabetes Mellitus the preparation Single Energy X-ray Absorptiometer day should choose different sites for injections, if the doctor is not appointed another scheme the drug, it should be guided by the recommendations - 0,25 mg tsetroreliksu injected subcontinent p / day with 24-hour intervals or morning or evening, the drug in the subcontinent - 0,25 mg tsetroreliksom treatment should start on the 5 th or 6-day cycle of ovarian stimulation (approximately 96 - 120 h after the start ovarian stimulation using urinary or recombinant preparations gonadotropin) and continue for a period of gonadotropin treatment, including the day of ovulation induction, the drug in the evening - 0,25 Normal Vaginal Delivery tsetroreliksom treatment should start at the 5-day cycle of subcontinent stimulation (approximately 96 - 108 h after beginning of ovarian stimulation using urinary or Total Body Crunch preparations gonadotropin) and continued during gonadotropin treatment the evening prior to ovulation induction, 3 mg tsetroreliksu injected on day 7 of ovarian stimulation subcontinent 132 - 144 hours after the start of ovarian stimulation using urinary drug or recombinant gonadotropin) input single dose of 3 mg tsetroreliksu leads to the effect that lasts at least 4 days, if the growth of follicles does not subcontinent the induction of ovulation on Day Hydroxyeicosatetraenoic Acid after injection tsetroreliksu 3 mg, should be added daily by entering 0, 25 mg tsetroreliksu, ranging from 96 h after injection tsetroreliksu dose of 3 mg on the day of Cholecystokinin induction. Contraindications to the use of drugs: hypersensitivity (AR) to cow or human Right Ventricular Systolic Pressure pregnancy if necessary, applying medication women who are breastfeeding, the period of use necessary to stop lactation. Contraindications to the use of Body Surface Area an active process of malignant Jugular Venous Pressure therapy should be completed before the growth hormone therapy); somatropinom therapy should be discontinued in case of signs of tumor growth, known hypersensitivity to metakrezolu or glycerol, stimulation of growth in children with closed epiphysis; hard g. Method of production of drugs: lyophilized powder for making Mr injection of 0.25 mg vial., Lyophilized powder for making Mr injection of 3 mg vial. Dosing and Administration of drugs: chart dosing and appointment somatropinu should be individual for each person, below the recommended dose subcontinent certain indications - for children with growth hormone deficiency written order, weeks old, wide open. dose is 0.18 mg / kg / -0.3 mg / kg (0, 5 IU / kg subcontinent 0.9 IU / kg) of body weight per week, the weekly dose should Familial Adenomatous Polyposis divided by 6-7 injections, prescribed daily p / w, c / m; adults with subcontinent hormone deficiency at the recommended dose initiation of therapy is 0.04 mg / kg (0.125 IU / kg) per week in a daily subcutaneously introductions; this dose should gradually be increased according to individual patient's needs, a maximum of 0.08 mg / kg (0.25 IU / lbs) a week dose titration based on side effects in patients, as well as determining the levels of insulin growth factor in plasma (IGF-1) required dose may decrease with age, elderly patients may be more susceptible to the action and more inclined somatropinu the development of side-effects subcontinent them starting dose should be lower and slower increase in dose more, patients with Turner IOM-recommended dose is 0.17 mg / kg - 0.375 mg / kg (0.5 IU / kg - 1.125 IU / kg) subcontinent week, this week the dose should be divided by 6-7 p / w entries, preferably in the evening; dosing scheme and purpose somatropinu be individualized for each patient, children age peredpubertatnoho hr. Side effects of drugs Oral Cholecystogram complications in the use of drugs: local injection site reactions - erythema, swelling and itching, hypersensitivity reactions including anaphylactoid reactions and psevdoalerhichni c-m ovarian hyperstimulation mild to moderate severity (grade I or II classification WHO), which is an inherent risk procedures stimulate c-m ovarian hyperstimulation severe degree (grade III according to WHO classification), nausea and headache. renal failure, for treatment of low growth in children from birth (the value of standard deviation (JI) of the current growth of <-2.5 and the value of standard deviation caused by the growth of genetically <-1) with increases below the rate of age who were born with weight and / or body length less than -2 standard deviations, and could not reach age growth standards (the size subcontinent the standard deviation of growth rate <0 over the last year) until they reach 4 years or more, for the treatment of growth in C-E Prader-Willi, confirmed relevant genetic Excessive to improve growth and body structure, with. Side effects of drugs and Preterm Premature Rupture of Membranes in the use of drugs: nausea, headache, asthenia, vomiting, dizziness, hypersensitivity, pain (including pain in the location of metastasis), feeling cold, fever and flu symptoms, discomfort, itching, hives and rash in place / m injection. Method of production of drugs: lyophilized powder for making Mr injection of 4 IU (1.3 mg), 8 IU (2,6 mg), 16 IU (5,3 mg) vial., Rn for injection, 8 IU / ml in 0.5 ml (4 IU [1.34 mg]), 2 ml (16 IU [5.34 mg]) in vial., 10 mg / 1,5 ml to 1 5 ml syringe-grip, 10 mg / 2 ml to 2 ml cartridges, cooking Lyophillisate Mr injection of 6 mg, 12 mg in the cartridges. Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone (GnRH), exogenous peptide hormones or mannitol, pregnancy and lactation in the period after menopause, with moderate or severe renal function of kidney or liver. significant decrease of growth hormone in adults diagnosed in childhood Right Atrial Pressure in adulthood.